Elastic and Thermoreversible Iongels by Supramolecular PVA/Phenol Interactions
Gisela C Luque1, Matías L Picchio2, Ana P S Martins3
1Instituto de Desarrollo Tecnológico para la Industria Química (INTEC) CONICET, Güemes 3450, Santa Fe, 3000, Argentina.
Abstract:
Iongels have attracted much attention over the years as ion-conducting soft materials for applications in several technologies including stimuli-responsive drug release and flexible (bio)electronics. Nowadays, iongels with additional functionalities such as electronic conductivity, self-healing, thermo-responsiveness, or biocompatibility are actively being searched for high demanding applications. In this work, a simple and rapid synthetic pathway to prepare elastic and thermoreversible iongels is presented. These iongels are prepared by supramolecular crosslinking between polyphenols biomolecules with a hydroxyl-rich biocompatible polymer such as poly(vinyl alcohol) (PVA) in the presence of ionic liquids. Using this strategy, a variety of iongels are obtained by combining different plant-derived polyphenol compounds (PhC) such as gallic acid, pyrogallol, and tannic acid with imidazolium-based ionic liquids, namely 1-ethyl-3-methylimidazolium dicyanamide and 1-ethyl-3-methylimidazolium bromide. A suite of characterization tools is used to study the structural, morphological, mechanical, rheological, and thermal properties of the supramolecular iongels. These iongels can withstand large deformations (40% under compression) with full recovery, revealing reversible transitions from solid to liquid state between 87 and 125 °C. Finally, the polyphenol-based thermoreversible iongels show appropriated properties for their potential application as printable electrolytes for bioelectronics.
More Related Videos
12:07Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
Published on: April 16, 2018
08:59A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
